1567372-00-2Relevant academic research and scientific papers
Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel
Winters, Michael P.,Subasinghe, Nalin,Wall, Mark,Beck, Edward,Brandt, Michael R.,Finley, Michael F.A.,Liu, Yi,Lubin, Mary Lou,Neeper, Michael P.,Qin, Ning,Flores, Christopher M.,Sui, Zhihua
, p. 2053 - 2056 (2014/05/06)
A novel series of substituted tetrahydropyrrolo[3,4-c]pyrazoles were investigated as blockers of the N-type calcium channel (Cav2.2 channels), a chronic pain target.
Synthesis of substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles by intramolecular nitrilimine cycloaddition
Winters, Michael P.,Teleha, Christopher A.,Sui, Zhihua
, p. 2150 - 2153 (2014/04/03)
Both substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles have been synthesized by the 3+2 intramolecular dipolar cycloaddition of nitrilimines to alkynes. This cyclization has been extended to more versatile 3-bromo derivatives by the use of alkynylbromides as dipolarophiles.
PYRROLOPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS
-
Page/Page column 38; 39; 40, (2014/03/22)
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: Formula. (I) wherein R1, R2 R3, Q, and G are defined herein.
